Download or read book Focus on the Japanese Pharmaceutical Industry written by Inframonitor (Firm) and published by . This book was released on 1997 with total page 290 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book They Do Well Who Do Good written by P. Reed Maurer and published by Trafford Publishing. This book was released on 2013-01-25 with total page 326 pages. Available in PDF, EPUB and Kindle. Book excerpt: They Do Well Who Do Good is a collection of articles written from 2000 to 2010 that document the changes in the Japan health care system and pharma industry. Changes considered impossible in the past became routine. As the decade ended, optimists and game changers leave the pessimists and status quo keepers behind. An attractive health care system evolved to care for an aging population with chronic diseases versus a young population with acute diseases. Japan wants the best health care the world has to offer, but choices must be made because resources to pay the bill are limited. In the beginning of the decade, you could compare Japanese pharma companies to a convoy of ships. Some big, some small, some fast, some slow, but all moved together. Ten years later, the convoy analogy was no longer useful. Some went abroad, others stayed home. Some divested noncore businesses; others did not. Some merged; others choose to go alone. Some changed their business models and cultures. Other rejected change and held on to their past. They Do Well Who Do Good is an insiders perspective on what it takes to succeed in Japans pharma market.
Download or read book It s Worth Doing written by P. Reed Maurer and published by Trafford Publishing. This book was released on 2011-12-29 with total page 297 pages. Available in PDF, EPUB and Kindle. Book excerpt: It's Worth Doing is a must read for anyone engaged in cross-border dealings with Japan in the pharmaceutical industry. This book offers a wealth of insight that you will find invaluable whether you are a veteran Japan hand or new to the nation, whether you are a senior executive or a newly hired medical representative. P. Reed Maurer shares his decades of experience and expertise through brilliantly penned colums that are always interesting, frequently funny, and sometimes--as in the title piece--gripping. In succinct and thoroughly enjoyable prose, Maurer imparts the esence of what you will need to know to succeed in Japan. The columns collected in this volume provide a sweeping historical perspective on Japan's pharmaceutical industry and an inside view of how companies in that industry compete. They furnish practical hints about how to manage and motivate people effectively at pharmaceutical operations in Japan and how to build a strong corporate image there. Maurer exposes myths and misunderstandings about doing business in Japan, refuting them with an objective clarity that is a joy to read. It's Worth Doing is even more, however, than a treasure trove of information and insight. True to its title, the book is a compelling reminder of why you are in the pharmaceutical business. Rob Schrull President Global Business Leaders Association
Download or read book The Japanese Pharmaceutical Industry written by Maki Umemura and published by Routledge. This book was released on 2011-03-02 with total page 245 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book explores why Japan, despite being a world leader in many high technology industries such as automobiles and consumer electronics, is only a minor player in the global pharmaceutical industry. Japan provides a huge market for pharmaceuticals as the second largest consumer of prescription drugs after the United States, and is a massive importer of prescription drugs, relying on discoveries made elsewhere. This book charts the development of the industry, from the devastation resulting from the Second World War to its performance in the present day. Focusing in particular on antibiotics and anticancer drugs, the book analyses factors that have prevented Japan from leading the rapid advances in science and technology that have occurred globally over recent decades. Looking at the pharmaceutical industry, the book argues that the Japanese government’s research and development policies were not sufficiently incentivising. It also shows how the nature of capitalism in Japan - which featured close relations between government and industry as well as between and within firms - was appropriate for nurturing industrial development in the immediate post-war decades, but became much less effective in later years.
Download or read book The Japanese Pharmaceutical Industry written by Lacy Glenn Thomas and published by Edward Elgar Publishing. This book was released on 2001 with total page 240 pages. Available in PDF, EPUB and Kindle. Book excerpt: Almost 90 per cent of new drugs are unavailable in Japan. This book presents an analysis of the nature, causes and consequences of this problem, contrasting the Japanese situation with the drug lag experienced in the US. The last chapters look at the various remedies available.
Download or read book Competition Law and Policy in the Japanese Pharmaceutical Sector written by Akira Negishi and published by Springer. This book was released on 2023-02-10 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: This is the first book published that focuses on competition law and policy in the Japanese pharmaceutical sector. It consists of chapters written and edited by academics who research the industry from various perspectives, including economics, competition law, pharmaceutical regulations, and intellectual property law. Competition policies involving pharmaceutical products attract attention from academics and policymakers worldwide. The pharmaceutical industry is regulated by drug laws that vary from country to country and are affected by differing practices and industrial structures. The book begins by examining drug regulations and trade practices in the industry that are peculiar to Japan and its healthcare system. It then presents the Japanese Antimonopoly Act and cases involving it, and discussions of current competition law issues in the Japanese pharmaceutical industry. The book also discusses innovation and intellectual property and economic analyses of pharmaceutical regulations and drug discovery. The chapters include comparative studies on Japanese regulations vs. those in the European Union and the United States. Japan is one of the biggest pharmaceutical markets in the world. With this in mind, the book provides “one-stop shopping” for anyone interested in pharmaceutical regulations in the country. Covering the basics but extending to in-depth explorations of complex problems, this book appeals not only to students and academics, pharmaceutical companies and regulators, but also to those dealing with real-world policy issues that encompass competition policy, intellectual property, and pharmaceutical regulation. Chapter 11 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com
Download or read book The Changing Economics of Medical Technology written by Institute of Medicine and published by National Academies Press. This book was released on 1991-02-01 with total page 225 pages. Available in PDF, EPUB and Kindle. Book excerpt: Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policiesâ€"as well as the involvement of numerous government agenciesâ€"affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.
Download or read book A Medicated Empire written by Timothy M. Yang and published by Cornell University Press. This book was released on 2021-06-15 with total page 428 pages. Available in PDF, EPUB and Kindle. Book excerpt: In A Medicated Empire, Timothy M. Yang explores the history of Japan's pharmaceutical industry in the early twentieth century through a close account of Hoshi Pharmaceuticals, one of East Asia's most influential drug companies from the late 1910s through the early 1950s. Focusing on Hoshi's connections to Japan's emerging nation-state and empire, and on the ways in which it embraced an ideology of modern medicine as a humanitarian endeavor for greater social good, Yang shows how the industry promoted a hygienic, middle-class culture that was part of Japan's national development and imperial expansion. Yang makes clear that the company's fortunes had less to do with scientific breakthroughs and medical innovations than with Japan's web of social, political, and economic relations. He lays bare Hoshi's business strategies and its connections with politicians and bureaucrats, and he describes how public health authorities dismissed many of its products as placebos at best and poisons at worst. Hoshi, like other pharmaceutical companies of the time, depended on resources and markets opened up, often violently, through colonization. Combining global histories of business, medicine, and imperialism, A Medicated Empire shows how the development of the pharmaceutical industry simultaneously supported and subverted regimes of public health at home and abroad.
Download or read book Japan in Focus Strategies for Innovation and Global Drug Development written by Centre for Medicines Research International and published by . This book was released on 1999 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book A Medicated Empire written by Timothy M. Yang and published by Cornell University Press. This book was released on 2021-06-15 with total page 354 pages. Available in PDF, EPUB and Kindle. Book excerpt: In A Medicated Empire, Timothy M. Yang explores the history of Japan's pharmaceutical industry in the early twentieth century through a close account of Hoshi Pharmaceuticals, one of East Asia's most influential drug companies from the late 1910s through the early 1950s. Focusing on Hoshi's connections to Japan's emerging nation-state and empire, and on the ways in which it embraced an ideology of modern medicine as a humanitarian endeavor for greater social good, Yang shows how the industry promoted a hygienic, middle-class culture that was part of Japan's national development and imperial expansion. Yang makes clear that the company's fortunes had less to do with scientific breakthroughs and medical innovations than with Japan's web of social, political, and economic relations. He lays bare Hoshi's business strategies and its connections with politicians and bureaucrats, and he describes how public health authorities dismissed many of its products as placebos at best and poisons at worst. Hoshi, like other pharmaceutical companies of the time, depended on resources and markets opened up, often violently, through colonization. Combining global histories of business, medicine, and imperialism, A Medicated Empire shows how the development of the pharmaceutical industry simultaneously supported and subverted regimes of public health at home and abroad.
Download or read book A Comparative Analysis of European Expansion Practices of Japanese and Non Japanese Pharmaceutical Companies written by Charles Richard Struby and published by . This book was released on 1998 with total page 318 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book The Japanese Pharmaceutical Industry written by Lee-Hwa Ting and published by . This book was released on 1985 with total page 116 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Case Study of the Japanese Pharmaceutical Industry written by Oliver C. Espeisse and published by . This book was released on with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book written by Society of Japanese Pharmacopoeia and published by . This book was released on 2001-02 with total page 168 pages. Available in PDF, EPUB and Kindle. Book excerpt: This book presents an analysis of the current trends and problems in the Japanese pharmaceutical industry, and attempts to find the key to future trends that will enhance the industry. With Japan being the world's second largest drugs market, the pharmaceutical industry is a key sector of the economy. The sector is, unlike the rest of the world, dominated by local companies, and the impact of major Western pharmaceutical companies has until recently been limited by the peculiar history and nature of Japanese medicine. Yet the globalisation of business is now affecting this sector, and the domestic companies are changing rapidly in order to compete more effectively, both at home and abroad, and to develop new medicines.
Download or read book The Viability of the Japanese Pharmaceutical Industry Internationally written by Yoshio Yano and published by . This book was released on 1980 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Japan s Pharmaceutical Industry written by Trade Bulletin Corporation (Japan) and published by . This book was released on 1965 with total page 95 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Takeda Chemical Industries Ltd written by V. Sarvani and published by . This book was released on 2003 with total page 20 pages. Available in PDF, EPUB and Kindle. Book excerpt: The case details the strategies adopted by Takeda Chemical Industries Ltd, Japan's leading pharmaceutical company, to grow into a global pharmaceutical major. The case conducts an in-depth study of Takeda's growth in the backdrop of the evolution of the Japanese pharmaceutical industry. Various strategies adopted by the company to grow in the domestic as well as international markets have been examined in detail. The case also explains in detail the reasons for the company deciding to concentrate on international expansion and establish itself as an R&D driven pharmaceutical company early 1990s onwards. Besides, the case also tries to analyze the future growth strategies adopted by Takeda in the light of the increasing competition from domestic and international players.
